Break Up with Your Makeup is an awareness program with an online resource designed to help women understand that they can finally TREAT, and stop CONCEALING with makeup, their rosacea redness!

Disclosure: I’m participating in the Break Up with Your Makeup Blogger Contest Sponsored by Galderma Laboratories, L.P.

Recently, I have been trying to break up with Makeup – Concealer and foundations mostly. If you walk around NYC, you will notice that most women are barefaced!  They do wear eye make up and maybe a touch of BB cream but foundation is way too heavy for this summer heatwave. The key to good skin is radiance, evenness and no red spots. I’m lucky to have never experienced symptoms of rosacea, but many of my close friends have. Rosacea is a treatable, chronic inflammatory skin condition and one of the most common symptoms is persistent facial redness. It’s estimated that 16MM Americans are affected by the condition.

Unfortunately, not many people know it is treatable and instead cake on the makeup to conceal the redness. There is a brand new product on the market now called Mirvaso, the only FDA-approved treatment for the persistent redness of rosacea.  Mirvaso is hosting this sweepstakes to raise awareness of the treatment, encouraging people to Break Up with Your Makeup. Mirvaso works fast, providing same-day results that last up to 12 hours before the redness returns, leaving users red-carpet ready!

If you would like to treat your skin and win this Cetaphil Collection – Tweet or IG @HEYDOYOU your bareface with no makeup! (Can be DM)

Good luck!

Important Safety Information
Indication: Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit WWW.FDA.GOV/MEDWATCH or call 1-800-FDA-1088.